← Open Payments lookup

MARK SAXON: Open Payments

NPI 1255389326 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,983 in 163 payments from 17 companies in 2025. Trend: 2023 $3,066 · 2024 $3,102 · 2025 $2,983

Food & beverage: $2,872Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.22$362
Otsuka America Pharmaceutical, Inc.21$362
ABBVIE INC.21$350
Teva Pharmaceuticals USA, Inc.16$346
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$284
Janssen Pharmaceuticals, Inc12$270
E.R. Squibb & Sons, L.L.C.16$262
Axsome Therapeutics, Inc.13$251
Vanda Pharmaceuticals Inc.4$116
Alkermes, Inc.6$111

Products named: INGREZZA, VRAYLAR, CAPLYTA, COBENFY, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, Auvelity.

Industry payments across PA — which companies pay providers there.